Chloral Hydrate Stats & Data

Lethal dose margin is narrow: deaths have occurred with ingestions as low as ~4–10 g; overdose presents with profound CNS depression, respiratory suppression, and risk of cardiac arrhythmias. Co-ingestion with alcohol or other depressants (opioids, benzodiazepines, GHB/GBL) markedly increases risk of loss of consciousness, respiratory depression, aspiration, and death—avoid these combinations entirely and place any unresponsive person in the recovery position while seeking emergency care. Chloral hydrate is metabolized primarily by alcohol dehydrogenase to trichloroethanol (active) and further to trichloroacetic acid; genetic variation and concurrent alcohol use can meaningfully alter both potency and duration between individuals. In cirrhosis or hepatic decompensation, chloral hydrate can precipitate or worsen hepatic encephalopathy; avoid use in significant liver disease and in untreated sleep apnea. Cardiac irritability/arrhythmia can occur in overdose and in susceptible individuals; those with structural heart disease or on other QT-/rhythm‑affecting drugs should avoid nonmedical use. Residual psychomotor impairment may persist into the next day due to metabolite half-lives; do not drive or operate machinery for at least a full night after dosing. Repeated frequent use rapidly builds tolerance and can cause dependence; withdrawal may begin within 12–24 hours after cessation in heavy users and may resemble alcohol/barbiturate withdrawal (including delirium)—medical supervision is strongly advised for dependent users. Oral and rectal routes can irritate mucosa; always dilute liquids and avoid concentrated solutions to reduce GI irritation; injection is strongly discouraged due to vein and tissue irritation. Products and syrups may vary in concentration; use an accurate milligram scale or clearly labeled pharmaceutical preparations to avoid dosing errors. Breast milk transfer occurs and may sedate infants; avoid during pregnancy and lactation unless medically supervised. If severe vomiting, chest pain, palpitations, confusion, or shallow breathing occur after use, seek emergency help immediately and avoid giving more depressants while awaiting care.